Kala Pharmaceuticals Inc.

NASDAQ: KALA · Real-Time Price · USD
8.24
0.17 (2.11%)
At close: Aug 15, 2025, 2:45 PM

Kala Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-37.23M -35.65M -38.51M -38.96M -38.72M -39.55M -42.2M -46.41M -8.64M -26.34M -44.82M -79.55M -136.75M -145.13M -142.6M -126.15M -125.97M -112.78M
Depreciation & Amortization
267K 261K 259K 260K 276K 292K 303K 313K 385K 457K 537K 669K 777K 884K 975K 1M 962K 930K
Stock-Based Compensation
8.68M 8.32M 8.39M 8.67M 9.04M 8.52M 7.46M 6.05M 4.97M 5.53M 7.01M 8.8M 11.4M 14.19M 16.09M 17.4M 17.45M 15.52M
Other Working Capital
464K -2.48M -1.49M -4.91M -2.52M 347K 3.18M 3.94M 310K -1.94M -1.07M 683K -3.32M 3.82M -1.83M 1.77M 5.78M 175K
Other Non-Cash Items
1.94M 1.99M 2.26M 4.92M -1.55M -1.4M -7K -1.65M 4.41M 3.57M 2.29M 20.59M 21.2M 22.37M 22.51M 3.56M 3.29M 3.07M
Deferred Income Tax
n/a n/a n/a -2.38M -2.38M -2.38M -2.38M n/a n/a n/a n/a 14K n/a 5.41M 5.42M 5.4M 5.41M 5K
Change in Working Capital
457K -2.29M -1.78M -4.99M 2.63M 5.43M 8.89M 7.73M -3.39M -3.31M 491K 808K -127K 2.6M -10.62M -7.46M -6.95M -10.19M
Operating Cash Flow
-25.88M -27.36M -29.38M -32.48M -30.71M -29.09M -27.93M -33.97M -46.68M -64.5M -78.91M -93.08M -103.5M -99.68M -108.23M -106.25M -105.81M -103.45M
Capital Expenditures
-20K -56K -69K -7K -337K -515K -610K -625K -382K -340K -313K -303K -594K -748K -886K -1.36M -1.57M -1.87M
Cash Acquisitions
n/a n/a n/a n/a n/a 47K 47K -62.86M -62.86M -62.91M -62.91M -4.61M -4.56M -4.56M -4.56M 50K n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a -9.87M -9.87M 118K 118K 9.98M 4.99M -4.99M -4.99M -4.99M n/a -56.53M -113.59M -113.59M
Sales Maturities Of Investments
n/a n/a n/a n/a 10M 9.95M 9.95M 4.95M -3.05M n/a n/a -71.25M -68.25M -48.25M n/a 113.58M 108.58M 85.58M
Other Investing Acitivies
-139K -139K -139K -139K n/a 47K 47K 58.04M 58.04M 58M 57.74M 71.38M 71.43M 71.43M 71.45M 56.34M 56.29M -243K
Investing Cash Flow
-175K -195K -208K -146K 9.66M -334K -429K -371K 54.82M 67.68M 62.72M 58.04M -2.15M 17.7M 70.8M 112.27M 49.95M -29.89M
Debt Repayment
-7.57M -5.07M -5.04M -18K n/a n/a -10M -10.01M -50.02M -50.03M -40.04M -40.04M -37K -263K -263K -262K -261K -33K
Common Stock Repurchased
13K 13K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
26K 56K -42K 1.92M 1.87M 1.87M -70K -2.04M -2.04M -2.04M 163K 163K 1.07M 1.13M 1.58M 1.73M 1.57M 2.28M
Financial Cash Flow
3.8M 21.3M 29.88M 25.77M 25.98M 14.09M 8.51M 37.76M -2.15M -5.24M -7.94M -39.57M 1.53M 7.39M 42.55M 63.12M 62.63M 64.76M
Net Cash Flow
-22.25M -6.26M 286K -6.86M 4.94M -15.33M -19.85M 3.42M 5.99M -2.06M -24.13M -74.6M -104.11M -74.59M 5.12M 69.13M 6.77M -68.58M
Free Cash Flow
-25.9M -27.42M -29.45M -32.49M -31.04M -29.6M -28.54M -34.59M -47.06M -64.84M -79.22M -93.38M -104.09M -100.43M -109.12M -107.61M -107.38M -105.32M